Diserens, A.C.

glioblastoma methylation patient tumor cancer fication gefitinib model analysis sample treatment expression glioma status value survival classi trial study tissue probe classi fication promoter outcome mgmt methylation status pathway association gbm-o effect dataset methylated neuropathol mgmt methylation table grade mutation prediction mgmt promoter methylation phase oncol mgmt-stp prognostic factor group anaplastic oligodendroglioma-like component university bene fit month temozolomide -450k probability amplification mgmt-stp 27 methylation status hm -450k research identi receptor response 1.0 therapy feature 0.0 0.8 number component mgmt-stp 27 model information gefitinib treatment 0.6 0.4 van den mgmt promoter 0.2 department concentration lausanne island phospho-protein